SEC Filing Summary: CopyTele, Inc. (10-Q)
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended April 30, 1997, for CopyTele, Inc. (Note: The input metadata referenced "Anixa Biosciences," but the filing text explicitly identifies the registrant as CopyTele, Inc.). The company is classified as a Development Stage Enterprise with no revenues since its inception in 1982. Its principal activities involve developing multi-functional telecommunications products featuring ultra-high resolution flat panel displays (E-PAPER) and operating a 55% owned joint venture in China, Shanghai CopyTele Electronics Co., Ltd. (SCE), which manufactures the MAGICOM(R) 2000 product.
Key Financial Metrics
| Metric | Six Months Ended April 30, 1997 | Six Months Ended April 30, 1996 | Inception to April 30, 1997 |
|---|---|---|---|
| Revenue (Sales) | $0 | $0 | $0 |
| Net Loss | ($2,981,425) | ($1,966,625) | ($31,739,805) |
| Net Loss Per Share | ($0.05) | ($0.04) | ($0.70) |
| Operating Expenses (SG&A) | $3,337,796 | $2,175,145 | $35,318,005 |
| Research & Development (included in SG&A) | $2,021,000 | $1,461,000 | $22,764,000 |
| Interest Income | $514,284 | $236,916 | $3,902,556 |
| Cash and Cash Equivalents (Ending) | $18,475,690 | $13,908,581 | $18,475,690 |
| Current Liabilities | $1,368,490 | $1,960,147 | N/A |
| Accumulated Deficit | ($31,739,805) | ($28,758,380) | ($31,739,805) |
Material Changes vs. Prior Period
- Increased Operating Loss: Net loss for the six months ended April 30, 1997, increased by approximately $1.01 million compared to the same period in 1996. This was driven by a $1.16 million increase in Selling, General, and Administrative (SG&A) expenses.
- Expense Drivers: The rise in SG&A was primarily due to increased engineering supplies (training components and product samples), higher compensation costs (marketing staff and scientific personnel for video/color R&D), and increased marketing and travel expenses.
- Joint Venture Losses: The company's share of losses from its Chinese joint venture (SCE) increased by $130,000 for the six-month period, reflecting higher costs as SCE entered initial production stages.
- Interest Income Growth: Interest income rose by approximately $277,000 year-over-year, attributed to higher interest rates and increased funds available for investment (weighted average of ~$19.65 million vs. ~$10.69 million).
- Cash Position: Cash decreased by approximately $3.69 million during the six-month period, primarily due to operating cash outflows of $4.72 million, partially offset by financing proceeds from stock option exercises ($1.40 million).
Guidance, Outlook, and Risks
- Liquidity Outlook: Management believes current funds are sufficient to maintain development efforts and meet the anticipated $550,000 capital contribution to a proposed second joint venture through the first quarter of fiscal 2000, assuming continued salary waivers by key executives.
- Capital Requirements: The company anticipates needing additional funding to satisfy NASD listing requirements (minimum $4 million in net tangible assets) and to support future joint venture capitalization beyond initial contributions.
- Product Risks: There is no assurance that the MAGICOM(R) 2000 product will generate significant revenue, achieve profitability, or avoid obsolescence due to competitive products. Success depends on SCE's production capabilities, pricing, and distributor performance.
- Joint Venture Status: SCE is in the initial stages of production and marketing. A second joint venture for electronic components is in the letter of intent stage, with potential capitalization up to $10 million.
- Accounting Note: The company accounts for stock-based compensation using the intrinsic value method (APB 25). Had they adopted SFAS 123, the pro forma net loss for the six months ended April 30, 1997, would have been ($9.43 million) instead of ($2.98 million).
Investor Verification Checklist
- Revenue Timeline: Verify the timeline for the first commercial sale of the MAGICOM(R) 2000 product, as the company has had zero revenue since inception.
- Joint Venture Viability: Assess the financial health and production capacity of the Shanghai CopyTele Electronics Co., Ltd. (SCE) joint venture, which is currently generating losses.
- Executive Compensation Waivers: Confirm the status of salary and pension benefit waivers by the Chairman, President, and senior personnel, as the liquidity runway depends on these continuing.
- NASD Compliance: Monitor the company's net tangible assets to ensure they remain above the $4 million threshold required for NASDAQ-NMS listing.
- Stock Option Dilution: Review the outstanding stock options (over 11 million under the 1993 Plan) and warrants to understand potential dilution upon exercise.